IRIS Accounts Production v23.3.1.45 10319672 director 1.9.22 31.8.23 31.8.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh103196722022-08-31103196722023-08-31103196722022-09-012023-08-31103196722021-08-31103196722021-09-012022-08-31103196722022-08-3110319672ns10:Originalns15:EnglandWales2022-09-012023-08-3110319672ns14:PoundSterlingns10:Original2022-09-012023-08-3110319672ns10:Originalns10:Director12022-09-012023-08-3110319672ns10:Original2022-09-012023-08-3110319672ns10:Original2023-08-3110319672ns10:Originalns10:PrivateLimitedCompanyLtd2022-09-012023-08-3110319672ns10:Originalns10:SmallEntities2022-09-012023-08-3110319672ns10:Originalns10:AuditExempt-NoAccountantsReport2022-09-012023-08-3110319672ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-09-012023-08-3110319672ns10:SmallCompaniesRegimeForAccountsns10:Original2022-09-012023-08-3110319672ns10:Originalns10:FullAccounts2022-09-012023-08-3110319672ns10:Originalns10:OrdinaryShareClass12022-09-012023-08-3110319672ns10:Originalns10:RegisteredOffice2022-09-012023-08-3110319672ns10:Original2022-08-3110319672ns10:Originalns5:CurrentFinancialInstruments2023-08-3110319672ns10:Originalns5:CurrentFinancialInstruments2022-08-3110319672ns5:ShareCapitalns10:Original2023-08-3110319672ns5:ShareCapitalns10:Original2022-08-3110319672ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-08-3110319672ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-08-3110319672ns10:Originalns5:FurnitureFittings2022-09-012023-08-3110319672ns10:Originalns5:ComputerEquipment2022-09-012023-08-3110319672ns10:Original2021-09-012022-08-3110319672ns10:Originalns5:FurnitureFittings2022-08-3110319672ns10:Originalns5:ComputerEquipment2022-08-3110319672ns10:Original2022-08-3110319672ns10:Originalns5:FurnitureFittings2023-08-3110319672ns10:Originalns5:ComputerEquipment2023-08-3110319672ns10:Originalns5:FurnitureFittings2022-08-3110319672ns10:Originalns5:ComputerEquipment2022-08-3110319672ns10:Originalns10:OrdinaryShareClass12023-08-31
REGISTERED NUMBER: 10319672 (England and Wales)















NONCLINICAL PROJECT MANAGEMENT LIMITED

REPORT OF THE DIRECTOR AND

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 AUGUST 2023






NONCLINICAL PROJECT MANAGEMENT LIMITED (REGISTERED NUMBER: 10319672)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023










Page

Company Information 1

Report of the Director 2

Balance Sheet 3

Notes to the Financial Statements 4


NONCLINICAL PROJECT MANAGEMENT LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 AUGUST 2023







DIRECTOR: Dr D G Deavall





REGISTERED OFFICE: Clifton Hampden
New Platt Lane
Cranage
Cheshire
CW4 8HS





REGISTERED NUMBER: 10319672 (England and Wales)

NONCLINICAL PROJECT MANAGEMENT LIMITED (REGISTERED NUMBER: 10319672)

REPORT OF THE DIRECTOR
FOR THE YEAR ENDED 31 AUGUST 2023


The director presents her report with the financial statements of the company for the year ended 31 August 2023.

DIRECTOR
Dr D G Deavall held office during the whole of the period from 1 September 2022 to the date of this report.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





Dr D G Deavall - Director


14 November 2023

NONCLINICAL PROJECT MANAGEMENT LIMITED (REGISTERED NUMBER: 10319672)

BALANCE SHEET
31 AUGUST 2023

2023 2022
Notes £    £   
FIXED ASSETS
Tangible assets 4 522 184

CURRENT ASSETS
Debtors 5 19,781 22,899
Cash at bank 417,234 349,680
437,015 372,579
CREDITORS
Amounts falling due within one year 6 (54,029 ) (48,235 )
NET CURRENT ASSETS 382,986 324,344
TOTAL ASSETS LESS CURRENT LIABILITIES 383,508 324,528

CAPITAL AND RESERVES
Called up share capital 7 1 1
Retained earnings 383,507 324,527
SHAREHOLDERS' FUNDS 383,508 324,528

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director and authorised for issue on 14 November 2023 and were signed by:



Dr D G Deavall - Director


NONCLINICAL PROJECT MANAGEMENT LIMITED (REGISTERED NUMBER: 10319672)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023


1. STATUTORY INFORMATION

Nonclinical Project Management Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

Turnover
Turnover is measured at the fair value of the consideration received or receivable net of VAT and trade
discounts. The policies adopted for the recognition of turnover are as follows:

Rendering of services
When the outcome of a transaction can be estimated reliably, turnover from consultancy services within the healthcare sector is recognised by reference to the stage of completion at the balance sheet date. Stage of completion is measured by reference to the date in which the service was provided.

Where the outcome cannot be measured reliably, turnover is recognised only to the extent of the expenses
recognised that are recoverable.

Interest receivable
Interest income is recognised using the effective interest method.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost
Computer equipment - Straight line over 3 years

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Tax
Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. It is measured at the amount expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

NONCLINICAL PROJECT MANAGEMENT LIMITED (REGISTERED NUMBER: 10319672)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2023


2. ACCOUNTING POLICIES - continued

Debtors and creditors receivable / payable within one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 September 2022 245 - 245
Additions - 599 599
At 31 August 2023 245 599 844
DEPRECIATION
At 1 September 2022 61 - 61
Charge for year 61 200 261
At 31 August 2023 122 200 322
NET BOOK VALUE
At 31 August 2023 123 399 522
At 31 August 2022 184 - 184

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 19,781 22,899

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Tax 40,252 30,163
VAT 11,920 15,995
Directors' current accounts 312 312
Accruals and deferred income 1,545 1,765
54,029 48,235

NONCLINICAL PROJECT MANAGEMENT LIMITED (REGISTERED NUMBER: 10319672)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2023


7. CALLED UP SHARE CAPITAL

Allotted and issued:
Number: Class: Nominal 2023 2022
value: £    £   
1 Share capital 1 1 1 1